Breaking News Instant updates and real-time market news.

BMRN

BioMarin

$88.30

-0.2 (-0.23%)

20:41
05/24/18
05/24
20:41
05/24/18
20:41

BioMarin approval of Palynziq is good news, says Piper Jaffray

Piper Jaffray analyst Christopher Raymond kept his Overweight rating and $114 price target on BioMarin after the FDA approval of its Palynziq treatment of PKU a day before PDUFA. The analyst adds that while the approval was expected, better labeling and higher pricing for the drug suggest potential upside for the stock price. Raymond notes that this approval has been the "lynchpin" to Biomarin's transformation to "sustainably high EPS", expecting shares to move "measurably" higher in the coming quarters.

  • 25

    May

  • 12

    Sep

BMRN BioMarin
$88.30

-0.2 (-0.23%)

05/22/18
EVER
05/22/18
NO CHANGE
EVER
BioMarin hemophilia A data remain 'intriguing,' says Evercore ISI
Evercore ISI analyst Josh Schimmer attributes the weakness in shares of BioMarin this morning to Factor VIII levels waning somewhat from one year to two years in the updated data from the Phase 1/2 study of Valrox. The company, however, remains optimistic that levels have stabilized based on preclinical models, Schimmer tells investors in a research note. He believes BioMarin's hemophilia A data remain "intriguing," but that long-term expression levels need to be watched and better understood. Schimmer points out Valrox is not a meaningful driver of his Outperform investment thesis BioMarin, which centers on upward revisions to outer-year estimates driven by pegvaliase.
05/22/18
PIPR
05/22/18
NO CHANGE
PIPR
Overweight
BioMarin weakness on valrox data a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond said following the presentation of longer-term data at the World Federation of Hemophilia that valrox remains "best-in-class" in terms of hemophilia A gene therapy and he believes the weakness in shares of BioMarin seems misplaced. While mean and median F8 levels did moderate from the 78-week data, management is confident based on preclinical experience that F8 activity is approaching a plateau, said Raymond. In terms of safety, prior concerns over F8 overexpression "just evaporated" with no F8 activity above the upper limit of normal in 6E13 vg/kg dose patients, added Raymond, who calls the weakness a buying opportunity and keeps an Overweight rating on BioMarin shares.
05/22/18
SBSH
05/22/18
NO CHANGE
SBSH
Neutral
Spark Therapeutics should not be higher on BioMarin data, says Citi
Citi analyst Mohit Bansal says shares of Spark Therapeutics (ONCE) should not trading high on BioMarin's (BMRN) updated hemophilia A data. The tapering of factor levels in BioMarin's data from year one to year two is not a positive for Spark as it is making investors concerned if Spark factor levels would also taper in long term, Bansal tells investors in a research note. Further, BioMarin's decision to run a controlled superiority trial could make the bar higher for Spark as the company may also have to do a similar trial to be competitive, the analyst adds. He has a Neutral rating on Spark shares. The stock in late morning trading is up $1.03 to $74.12.
05/22/18
JEFF
05/22/18
NO CHANGE
Target $116
JEFF
Buy
BioMarin 'raised efficacy bar' with valrox Phase 3 modification, says Jefferies
Jefferies analyst Eun Yang said BioMarin's updated Phase 1/2 data for valrox for hemophilia A showed a decline in F8 levels at two years compared to 1.5 years, but she typified the results as showing "continuing strong efficacy" and noted the company seems confident of entering a stable expression phase. The company also announced a modification to its ongoing GENEr8-1 Phase 3 trial to show superiority versus the current standard of care, which raises the bar for efficacy but also for potential clinical risks, though the change supports the company's commercial rationale, said Yang, who keeps her Buy rating and $116 price target on BioMarin shares.

TODAY'S FREE FLY STORIES

BHP

BHP Billiton

$47.63

-1.34 (-2.74%)

21:07
06/19/18
06/19
21:07
06/19/18
21:07
Periodicals
BHP to sell Cerro Colorado copper mine to EMR Capital for $230M, Reuters says »

BHP has reached an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALA

Kala Pharmaceuticals

$13.38

-0.36 (-2.62%)

21:04
06/19/18
06/19
21:04
06/19/18
21:04
Recommendations
Kala Pharmaceuticals analyst commentary at Wells Fargo »

Kala Pharma's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

CAFD

8point3 Energy

$12.42

0.01 (0.08%)

20:21
06/19/18
06/19
20:21
06/19/18
20:21
Hot Stocks
8point3 Energy closes merger transaction »

8point3 Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$46.29

-0.25 (-0.54%)

20:15
06/19/18
06/19
20:15
06/19/18
20:15
Recommendations
Oracle analyst commentary at MUFG »

Oracle cloud business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TLSYY

Telstra

$0.00

(0.00%)

20:01
06/19/18
06/19
20:01
06/19/18
20:01
Hot Stocks
Telstra sees FY19 EBITDA $8.7B-$9.4B »

To cut 8,000 staff and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXC

Exelon

$41.61

-0.11 (-0.26%)

, FSLR

First Solar

$52.21

0.39 (0.75%)

19:52
06/19/18
06/19
19:52
06/19/18
19:52
Periodicals
First Solar, Exelon push for carbon tax legislation, Bloomberg reports »

Exelon (EXC) has…

EXC

Exelon

$41.61

-0.11 (-0.26%)

FSLR

First Solar

$52.21

0.39 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$27.40

0.63 (2.35%)

, ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

19:21
06/19/18
06/19
19:21
06/19/18
19:21
Recommendations
Flexion, Anika Therapeutics analyst commentary at Wells Fargo »

Flexion to benefit from…

FLXN

Flexion

$27.40

0.63 (2.35%)

ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

ENSG

Ensign Group

$38.55

0.06 (0.16%)

19:07
06/19/18
06/19
19:07
06/19/18
19:07
Hot Stocks
Ensign Group subsidiary acquires office building in San Juan Capistrano »

The Ensign Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNOV

MediciNova

$8.37

-0.03 (-0.36%)

19:01
06/19/18
06/19
19:01
06/19/18
19:01
Hot Stocks
MediciNova receives Notice of Allowance from JPO for new patent covering MN-001 »

MediciNova announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

19:00
06/19/18
06/19
19:00
06/19/18
19:00
Hot Stocks
USMC awards BAE Systems $198M amphibious combat vehicle contract »

The U.S. Marine Corps has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$228.20

-3.185 (-1.38%)

18:59
06/19/18
06/19
18:59
06/19/18
18:59
Periodicals
Goldman plans to invest $500M in women-run companies, Reuters says »

Goldman Sachs intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

NTIP

Network-1 Technologies

$3.00

(0.00%)

, SYNA

Synaptics

$48.81

-0.35 (-0.71%)

18:50
06/19/18
06/19
18:50
06/19/18
18:50
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Network-1…

NTIP

Network-1 Technologies

$3.00

(0.00%)

SYNA

Synaptics

$48.81

-0.35 (-0.71%)

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

PRTA

Prothena

$14.99

0.43 (2.95%)

LZB

La-Z-Boy

$33.25

0.1 (0.30%)

ORCL

Oracle

$46.29

-0.25 (-0.54%)

FDX

FedEx

$258.35

-5.295 (-2.01%)

ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

KIN

Kindred Biosciences

$10.00

-0.55 (-5.21%)

SBUX

Starbucks

$57.43

0.22 (0.38%)

GE

General Electric

$12.96

-0.24 (-1.82%)

VALE

Vale

$12.97

-0.21 (-1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 19

    Jun

  • 19

    Jun

  • 22

    Jun

  • 28

    Jun

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

  • 20

    Sep

  • 21

    Sep

  • 20

    Jun

SD

SandRidge Energy

$17.03

1.21 (7.65%)

, IEP

Icahn Enterprises

$72.11

-0.62 (-0.85%)

18:44
06/19/18
06/19
18:44
06/19/18
18:44
Hot Stocks
SandRidge Energy reaches pact with Icahn Capital on board composition »

SandRidge Energy (SD)…

SD

SandRidge Energy

$17.03

1.21 (7.65%)

IEP

Icahn Enterprises

$72.11

-0.62 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$106.20

-0.85 (-0.79%)

18:32
06/19/18
06/19
18:32
06/19/18
18:32
Hot Stocks
Disney names Jennifer lee Walt Disney Animation Studios CCO »

Disney announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$6.20

0.05 (0.81%)

18:32
06/19/18
06/19
18:32
06/19/18
18:32
Syndicate
Trillium Therapeutics announces 'at-the-market' issuance program »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$32.39

0.19 (0.59%)

, GOOG

Alphabet

$1,167.86

-5.77 (-0.49%)

18:17
06/19/18
06/19
18:17
06/19/18
18:17
Periodicals
AT&T in discussions to purchase AppNexus, Cheddar reports »

AT&T (T) is in talks…

T

AT&T

$32.39

0.19 (0.59%)

GOOG

Alphabet

$1,167.86

-5.77 (-0.49%)

GOOGL

Alphabet Class A

$1,178.29

-5.69 (-0.48%)

FB

Facebook

$197.46

-0.84 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Oct

AAL

American Airlines

$41.51

-0.93 (-2.19%)

18:14
06/19/18
06/19
18:14
06/19/18
18:14
Periodicals
Breaking Periodicals news story on American Airlines »

American Airlines offers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

ZN

Zion Oil & Gas

$3.13

(0.00%)

18:13
06/19/18
06/19
18:13
06/19/18
18:13
Hot Stocks
Zion Oil & Gas to start operations at Megiddo-Jezreel #1 as soon as June 21 »

Zion Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

0.22 (0.38%)

18:10
06/19/18
06/19
18:10
06/19/18
18:10
Hot Stocks
Starbucks says China third party delivery 'was not a good experience' »

Comments taken from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

EQH

AXA Equitable

$20.94

-0.01 (-0.05%)

18:07
06/19/18
06/19
18:07
06/19/18
18:07
Hot Stocks
Breaking Hot Stocks news story on AXA Equitable »

AXA Equitable reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

EQH

AXA Equitable

$20.94

-0.01 (-0.05%)

18:06
06/19/18
06/19
18:06
06/19/18
18:06
Earnings
AXA Equitable reports Q1 non-GAAP EPS 83c, consensus 82c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

BAESY

BAE Systems

$0.00

(0.00%)

18:06
06/19/18
06/19
18:06
06/19/18
18:06
Periodicals
USMC awards BAE contract to deliver new amphibious vehicles, Reuters says »

The U.S. Marine Corp has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNI

ATN International

$55.30

0.57 (1.04%)

18:04
06/19/18
06/19
18:04
06/19/18
18:04
Hot Stocks
ATN International acquires Geoverse LLC, terms not disclosed »

Geoverse, LLC, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

, GE

General Electric

$12.96

-0.24 (-1.82%)

18:01
06/19/18
06/19
18:01
06/19/18
18:01
Hot Stocks
Walgreens Boots Alliance to replace General Electric in DJIA at open on 6/26 »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

GE

General Electric

$12.96

-0.24 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

HPE

HP Enterprise

$15.90

-0.02 (-0.13%)

18:01
06/19/18
06/19
18:01
06/19/18
18:01
Hot Stocks
HP Enterprise to invest $4B in Intelligent Edge technologies »

Hewlett Packard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.